Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device-Drug Alliance Aims To Temper Comparative Effectiveness Impact

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed, the Pharmaceutical Research & Manufacturers of America, and the Biotechnology Industry Organization have formed a coalition to promote an industry agenda on comparative clinical effectiveness
Advertisement

Related Content

Biotech, Device Industries Team Up On Patent Reform
Biotech, Device Industries Team Up On Patent Reform
Much Research, Little Action On Comparative Effectiveness
Device Makers Cite Special Concerns With Comparative Effectiveness
Device Makers Cite Special Concerns With Comparative Effectiveness
Advertisement
UsernamePublicRestriction

Register

MT026485

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel